Public Comment

ASTRO posts drafts of clinical practice guidelines, white papers and other documents for public comment before they are finalized and sent to ASTRO's Board of Directors for approval. The public comment period is an integral part of guidance development, and is preceded by a series of reviews and revisions and may be followed by a final peer review if the document is submitted to a journal for publication. ASTRO encourages those in the radiation oncology field to comment and then share with colleagues, producing a more robust public response.

ASTRO seeks public comment on Patient-centered Care Pathway for Molecular-Targeted Radiopharmaceutical Therapies (MTRTs)

This path of care guidance seeks to identify an early consensus on the steps in the emerging process of care for cancer patients receiving MTRT and to identify optimal workflows to support safe, high-quality care by qualified professionals. These recommendations are based on the consensus of the Theranostics Work Group comprised of members from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society for Radiation Oncology (ASTRO). Additionally, this guidance and the format of this document draws from aspects of the Patient-Centered Oncology Practice Standards of the National Committee of Quality Assurance(NCQA) and the National Academy of Medicine, formerly known as the Institute of Medicine, workshop on patient-centered cancer treatment planning.

Comments can be submitted via webform through Monday July 6, 2020.